Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertrophic Obstructive Cardiomyopathy (HOCM)”

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07107373
What this trial is testing

Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Bristol-Myers Squibb 150
Not applicableUnknownNCT02492399
What this trial is testing

Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM)

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy
Meshalkin Research Institute of Pathology of Circulation 60
Early research (Phase 1)Study completedNCT04783766
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of CK-3773274

Who this might be right for
Obstructive Hypertrophic CardiomyopathyHealthy Adult Subjects
Corxel Pharmaceuticals 28
Large-scale testing (Phase 3)Study completedNCT05186818
What this trial is testing

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Cytokinetics 282
Not applicableStudy completedNCT00001530
What this trial is testing

Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Cardiomyopathy, Hypertrophic
National Heart, Lung, and Blood Institute (NHLBI) 120
Testing effectiveness (Phase 2)Looking for participantsNCT07721025
What this trial is testing

Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy

Who this might be right for
Friedreich AtaxiaCardiomyopathy, Secondary
Lexeo Therapeutics 26
Large-scale testing (Phase 3)Study completedNCT03470545
What this trial is testing

Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
MyoKardia, Inc. 251
Not applicableLooking for participantsNCT07006493
What this trial is testing

REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy, Obstructive
SuZhou Sinus Medical Technologies Co.,Ltd 124
Not applicableStudy completedNCT06397092
What this trial is testing

Anesthetic Management for TA-BSM in HOCM

Who this might be right for
AnesthesiaTransapical Beating-heart Septal MyectomyHypertrophic Cardiomyopathy
Tongji Hospital 120
Post-approval studies (Phase 4)Active Not RecruitingNCT07004972
What this trial is testing

Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Who this might be right for
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06412666
What this trial is testing

Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Who this might be right for
PediatricSymptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics 65
Not applicableStudy completedNCT05687487
What this trial is testing

Residual or Recurrent Obstruction After Septal Myectomy

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy
Chinese Academy of Medical Sciences, Fuwai Hospital 56
Not applicableEnded earlyNCT04770142
What this trial is testing

First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy
Tau-MEDICAL Co., Ltd. 5
Not applicableStudy completedNCT00001534
What this trial is testing

Long Term Effects of Enalapril and Losartan on Genetic Heart Disease

Who this might be right for
Hypertrophic CardiomyopathyLeft Ventricular HypertrophyMyocardial Ischemia
National Heart, Lung, and Blood Institute (NHLBI) 112
Testing effectiveness (Phase 2)Looking for participantsNCT07023614
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc. 165
Large-scale testing (Phase 3)Study completedNCT05174416
What this trial is testing

Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
LianBio LLC 81
Not applicableEnrolling By InvitationNCT06683872
What this trial is testing

Evaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
Zhejiang Provincial People's Hospital 200
Not applicableLooking for participantsNCT06023186
What this trial is testing

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Michael Ayers 20
Testing effectiveness (Phase 2)Study completedNCT04826185
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc. 67
Post-approval studies (Phase 4)Active Not RecruitingNCT06112743
What this trial is testing

Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Cardiomyopathy, Hypertrophic
Bristol-Myers Squibb 63
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation